Form 8-K - Current report:
SEC Accession No. 0001570562-20-000072
Filing Date
2020-04-16
Accepted
2020-04-16 16:53:54
Documents
3
Period of Report
2020-04-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a416208k.htm 8-K 48951
2 EXHIBIT 99.1 a991.htm EX-99.1 14881
3 evoluslogohorizontal.jpg GRAPHIC 270362
  Complete submission text file 0001570562-20-000072.txt   417112
Mailing Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660
Business Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660 (949) 284-4555
Evolus, Inc. (Filer) CIK: 0001570562 (see all company filings)

EIN.: 461385614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38381 | Film No.: 20796916
SIC: 2834 Pharmaceutical Preparations